Aminopyridinecarboxamide-based inhibitors: Structure-activity relationship

被引：5

作者：

Bonafoux, Dominique F. ^{[1
]}

Bonar, Sheri L. ^{[2
]}

Clare, Michael ^{[1
]}

Donnelly, Ann M. ^{[2
]}

Glaenzer, Jeanette L. ^{[1
]}

Guzova, Julia A. ^{[2
]}

Huang, He ^{[1
]}

Kishore, Nandidni N. ^{[2
]}

Koszyk, Francis J. ^{[1
]}

Lennon, Patrick J. ^{[1
]}

Libby, Adam ^{[1
]}

Mathialagan, Sumathy ^{[2
]}

Oburn, David S. ^{[1
]}

Rouw, Sharon A. ^{[2
]}

Sommers, Cynthia D. ^{[2
]}

Tripp, Catherine S. ^{[2
]}

Vanella, Lori J. ^{[2
]}

Weier, Richard ^{[1
]}

Wolfson, Serge G. ^{[1
]}

Huang, Horng-Chih ^{[1
]}

机构：

[1] Pfizer Inc, Dept Med Chem, St Louis, MO 63017 USA

[2] Pfizer Inc, Dept Biol, St Louis, MO 63017 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2010年 / 18卷 / 01期

关键词：

IKK2; NFkB; Inhibitor; NF-KAPPA-B; IKK-2; INHIBITOR; DISCOVERY;

D O I：

10.1016/j.bmc.2009.10.040

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Series of aminopyridinecarboxamide-based inhibitors were synthesized and tested against human recombinant IKK-2 and in IL-1 beta stimulated synovial. broblasts. The 2-amino-5-chloropyridine-4-carboxamides were identified as the most potent inhibitors with improved cellular activity. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：403 / 414

页数：12

共 50 条

[1] Aminopyridinecarboxamide-based inhaled IKK-2 inhibitors for asthma and COPD: Structure-activity relationship
Xie, Jin
Poda, Gennadiy I.
Hu, Yiding
Chen, Natalie X.
Heier, Richard F.
Wolfson, Serge G.
Reding, Matthew T.
Lennon, Patrick J.
Kurumbail, Ravi G.
Selness, Shaun R.
Li, Xiong
Kishore, Nandini N.
Sommers, Cynthia D.
Christine, Lori
Bonar, Sheri L.
Venkatraman, Neetu
Mathialagan, Sumathy
Brustkern, Sarah J.
Huang, Horng-Chih
BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (03) : 1242 - 1255
[2] Structure-Activity Relationship of Propargylamine-Based HDAC Inhibitors
Wuensch, Matthias
Senger, Johanna
Schultheisz, Philipp
Schwarzbich, Sabrina
Schmidtkunz, Karin
Michalek, Carmela
Klass, Michaela
Goskowitz, Stefanie
Borchert, Philipp
Praetorius, Lucas
Sippl, Wolfgang
Jung, Manfred
Sewald, Norbert
CHEMMEDCHEM, 2017, 12 (24) : 2044 - 2053
[3] Structure-Activity Relationship for Thiirane-Based Gelatinase Inhibitors
Lee, Mijoon
Ikejiri, Masahiro
Klimpel, Dennis
Toth, Marta
Espahbodi, Mana
Hesek, Dusan
Forbes, Christopher
Kumarasiri, Malika
Noll, Bruce C.
Chang, Mayland
Mobashery, Shahriar
ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (06): : 490 - 495
[4] STRUCTURE-ACTIVITY RELATIONSHIP OF INHIBITORS OF HYDROXYAPATITE FORMATION
WILLIAMS, G
SALLIS, JD
BIOCHEMICAL JOURNAL, 1979, 184 (01) : 181 - 184
[5] Structure-activity relationship of insect molting inhibitors
Nakagawa, Yoshiaki
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
[6] Structure-activity relationship study of tryptophan-based butyrylcholinesterase inhibitors
Meden, Anze
Knez, Damijan
Malikowska-Racia, Natalia
Brazzolotto, Xavier
Nachon, Florian
Svete, Jurij
Salat, Kinga
Groselj, Uros
Gobec, Stanislav
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 208
[7] Synthesis, activity and structure-activity relationship of noroviral protease inhibitors
Deng, Lisheng
Muhaxhiri, Zana
Estes, Mary K.
Palzkill, Timothy
Prasad, B. V. Venkataram
Song, Yongcheng
MEDCHEMCOMM, 2013, 4 (10) : 1354 - 1359
[8] QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP OF INHIBITORS OF NONENZYMATIC GLYCATION
RAVI, VN
WALLER, CL
BEATY, C
GOLDBERG, M
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1994, 35 (04) : 1929 - 1929
[9] STRUCTURE-ACTIVITY RELATIONSHIP FOR INHIBITORS OF CYCLIC AMP PHOSPHODIESTERASE
LUCACCHINI, A
ROSSI, CA
RANIERI, M
MONTALI, U
BOLLETTINO DELLA SOCIETA ITALIANA DI BIOLOGIA SPERIMENTALE, 1972, 48 (1-2): : 17 - +
[10] Structure-activity relationship study of novel necroptosis inhibitors
Teng, X
Degterev, A
Jagtap, P
Xing, XC
Choi, S
Denu, R
Yuan, JY
Cuny, GD
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (22) : 5039 - 5044

← 1 2 3 4 5 →